High Yield Dividend Stocks Setting New Yearly Highs

JNJ Dividend Yield data by YCharts

Johnson & Johnson (JNJ)

Background: The world's sixth-largest consumer health company. The world's largest and most diverse medical devices and diagnostics company. The world's fifth-largest biologics company and the world's eighth-largest pharmaceuticals company.

52-Week Range: $61.71 to $72.74

Book Value: $20.95

Price To Book: 3.3

Earnings Payout Percentage: 77%

Investors are receiving $2.44 in dividends for a yield of 3.5%. On Aug. 29, I wrote about J&J and the closing price was $67.37. It didn't take long for J&J to move higher, and along with the capital gain, J&J paid 61 cents in dividends since. Conversely, the S&P 500 (SPY) didn't fare quite as well. The overall market is down slightly.

Analysts as a whole like this company. Currently, Johnson & Johnson has 14 buy recommendations out of 26 analysts covering the company, along with 11 holds, and one rates it as a sell.

Shares have really appreciated, gaining 12% in the last year, and the average analyst target price is $75.13.

>>> Also see: Fortinet It and Forget It

With short interest above 5%, investors will want to monitor changes to know if short sellers turn up the warning signals. Otherwise, the current 5.8% of the float short is relatively small and not a major concern. It's actually declined since my Aug. 29 article, a very good sign.

JNJ Payout Ratio TTM data by YCharts
-----------------------------------------------------

« First ‹ Previous 1 2 3 4 5 6 Next › Last »